Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Wilfredo Ruiz-Vazquez"'
Autor:
Abel Trujillo-Ocampo, Hyun-Woo Cho, Sumedha Pareek, Wilfredo Ruiz-Vazquez, Michael Clowers, Sung-Eun Lee, Jin S. Im
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Externí odkaz:
https://doaj.org/article/94df7463f2524ac9a4c2478458801801
Autor:
Abel Trujillo-Ocampo, Hyun-Woo Cho, Michael Clowers, Sumedha Pareek, Wilfredo Ruiz-Vazquez, Sung-Eun Lee, Jin S. Im
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Invariant natural killer T (iNKT) cells are innate-like T lymphocytes cells that recognize glycolipid antigens associated with CD1d, non-classical antigen presenting proteins. They can drive either pro-inflammatory (Th-1) or anti-inflammatory (Th-2)
Externí odkaz:
https://doaj.org/article/700e1092987643f3aa10594ac3df3198
Autor:
Wilfredo Ruiz-Vazquez, Sung-Eun Lee, Jin S. Im, Sumedha Pareek, Abel Trujillo-Ocampo, Michael J. Clowers, Hyun Y.U.N.W.O.O. Cho
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Invariant natural killer T (iNKT) cells are innate-like T lymphocytes cells that recognize glycolipid antigens associated with CD1d, non-classical antigen presenting proteins. They can drive either pro-inflammatory (Th-1) or anti-inflammatory (Th-2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aad8e64cd7611d3d84a8049685010b2f
https://doi.org/10.3389/fimmu.2021.689959
https://doi.org/10.3389/fimmu.2021.689959
Autor:
Linghua Wang, Adi Diab, Lara Bashoura, Naval Daver, Vickie R. Shannon, Ajay Sheshadri, Dimitrios P. Kontoyiannis, Margarita Divenko, Rohit Mathur, Jin S. Im, Scott E. Evans, Curtis Gumbs, Sang T. Kim, Diwakar D. Balachandran, Samantha Tippen, Hagop M. Kantarjian, Prajwal Boddu, Aung Naing, Farhad Ravandi, Guillermo Garcia-Manero, Roza Nurieva, Andrew Futreal, Saadia A. Faiz, Wilfredo Ruiz Vazquez, Sattva S. Neelapu
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, Vol 11 (2021)
Frontiers in Immunology, Vol 11 (2021)
Patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) treated with immune checkpoint inhibitors (ICIs) are at risk of pneumonitis as well as pneumonia (combined henceforth as ICI-related pulmonary complications). Little is kno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::406c41306f7651d425db10292de0cf4e
http://europepmc.org/articles/PMC7859512
http://europepmc.org/articles/PMC7859512
Autor:
Sung-Eun Lee, Richard E. Champlin, Gheath Alatrash, Hyun-Woo Cho, Abel Trujillo-Ocampo, P. Andrew Futreal, Naval Daver, Koichi Takahashi, Wilfredo Ruiz Vazquez, Jeffrey J. Molldrem, Jin S. Im, Hagop M. Kantarjian, Guillermo Garcia-Manero, Feng Wang
Publikováno v:
Blood. 136:4-4
Backgound Myelodysplastic Syndrome (MDS) is a disorder in hematopoiesis where mutations may alter the epigenetic landscape facilitating leukemogenesis. Such epigenetic alterations may contribute to the immune-dysregulation leading to ineffective anti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6f3dacbc2740912ea95b47a10e696fb2
https://doi.org/10.1182/blood-2020-136963
https://doi.org/10.1182/blood-2020-136963
Autor:
Hyun Y.U.N.W.O.O. Cho, Jeffrey J. Molldrem, Jin S. Im, Amanda C. Herrmann, Abel Trujillo-Ocampo, Elizabeth J. Shpall, Hong He, Mariam Qazilbash, Qing Ma, Steven A. Porcelli, Daniel Li, Wilfredo Ruiz-Vazquez, Andrew B. Thornton
Background aims CD1d-restricted invariant natural killer (iNK) T cells are rare regulatory T cells that may contribute to the immune-regulation in allogeneic stem cell transplantation (ASCT). Here, we sought to develop an effective strategy to expand
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e14d1a91523a2f34f203ba26a36c9057
https://europepmc.org/articles/PMC6262231/
https://europepmc.org/articles/PMC6262231/
Autor:
Sang T. Kim, Ajay Sheshadri, Vickie Shannon, Dimitrios P. Kontoyiannis, Hagop Kantarjian, Guillermo Garcia-Manero, Farhad Ravandi, Jin S. Im, Prajwal Boddu, Lara Bashoura, Diwakar D. Balachandran, Scott E. Evans, Saadia Faiz, Wilfredo Ruiz Vazquez, Margarita Divenko, Rohit Mathur, Samantha P. Tippen, Curtis Gumbs, Sattva S. Neelapu, Aung Naing, Linghua Wang, Adi Diab, Andrew Futreal, Roza Nurieva, Naval Daver
Publikováno v:
Frontiers in Immunology, Vol 11 (2021)
Patients with acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) treated with immune checkpoint inhibitors (ICIs) are at risk of pneumonitis as well as pneumonia (combined henceforth as ICI-related pulmonary complications). Little is kno
Externí odkaz:
https://doaj.org/article/dc5a725f54754ba59720d7c06fbd8deb